Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Daniele Lages | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Mrs . Daniele Lages | Immunology and Microbiology | Best Researcher Award

Doutoranda at Universidade Federal de Minas Gerais , Brazil

Daniele dos Santos Lages is a dedicated Brazilian researcher specializing in public health, with a focus on epidemiology, particularly related to leprosy (hanseníase). Her work combines academic rigor with social impact, addressing neglected diseases and strengthening primary healthcare systems. She is fluent in Portuguese, English, and Spanish, which allows her to collaborate across international boundaries. Daniele has received multiple academic honors, presented research at notable conferences, and published significant contributions on disease surveillance and public health policy. Her involvement in research groups, notably NEPHANS at UFMG, underlines her leadership in advancing public health research in Brazil. She has also completed various international and national health training programs, demonstrating a commitment to lifelong learning and capacity building. Daniele’s blend of academic achievement, research productivity, and social responsiveness positions her as an influential figure in public health, making her a strong candidate for recognition through research and academic excellence awards.

Professional Profile 

Education🎓

Daniele dos Santos Lages has pursued an outstanding academic path focused on nursing and public health at the Federal University of Minas Gerais (UFMG), one of Brazil’s top universities. She earned her bachelor’s degree in Nursing, followed by a specialization in Family Health (Residência Multiprofissional) from the same institution. She further advanced her academic qualifications by completing a Master’s degree and is currently a doctoral candidate in Nursing with a focus on Public Health at UFMG. Throughout her educational journey, she has consistently focused on public health issues, particularly in disease prevention and control, with a strong emphasis on leprosy. Her academic background is complemented by several national and international certifications in epidemiology, health surveillance, and neglected tropical diseases, many of which are issued by globally recognized bodies like WHO and PAHO. This combination of formal education and specialized training gives her a strong foundation for conducting impactful, evidence-based health research.

Professional Experience📝

Daniele has built a meaningful professional career around research and public health services, with an emphasis on leprosy control and primary healthcare strategies. She is an active member of the NEPHANS research group at UFMG, where she contributes to epidemiological studies, health surveillance analysis, and healthcare delivery systems. Her work includes data-driven policy evaluations and healthcare service assessments focused on vulnerable populations affected by neglected diseases. Daniele has authored and co-authored several academic papers and posters, many of which were presented at national and international conferences, receiving awards for scientific excellence. In addition to her research, she has participated in teaching, public health campaigns, and collaborative projects with health institutions and government agencies. Her hands-on experience with Brazil’s Unified Health System (SUS) has informed her practical understanding of public health challenges. By combining academic insight with field engagement, Daniele bridges the gap between theory and practice, making her contributions highly relevant and applicable.

Research Interest🔎

Daniele dos Santos Lages is deeply committed to advancing research in public health, with her primary focus on the epidemiology of neglected tropical diseases, particularly leprosy (hanseníase). Her academic and professional endeavors revolve around disease surveillance, healthcare accessibility, health equity, and the effectiveness of Brazil’s Unified Health System (SUS). Daniele is particularly interested in the social determinants of health, evaluating how poverty, education, and access to care affect disease prevalence and treatment outcomes. She explores the intersection of clinical practice and public policy to propose practical, evidence-based improvements in primary care. Her research integrates quantitative epidemiological data with qualitative insights from affected populations, aiming to inform public health strategies and reduce disease-related stigma. As a doctoral researcher, she is involved in multidisciplinary investigations that align with global health priorities and the Sustainable Development Goals, particularly those concerning the elimination of neglected diseases and the promotion of universal health coverage.

Award and Honor🏆

Daniele dos Santos Lages has been recognized multiple times for her academic excellence and impactful research in public health. Among her accolades, she received awards for the best oral presentation at national conferences, highlighting her effective communication and the societal relevance of her work. She has also been granted scholarships and research support through prestigious programs like PROBIC/FAPEMIG, affirming the merit of her scientific inquiries. Her participation in highly competitive international training programs hosted by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) further underscores her status as a distinguished emerging scholar. These programs focus on epidemiological intelligence, health surveillance, and strategies to combat neglected tropical diseases. Daniele’s consistent recognition reflects her commitment to scientific rigor, community health, and leadership within Brazil’s healthcare research community. These honors not only validate her contributions but also inspire her continued efforts to advance evidence-based practices in public health and epidemiology.

Research Skill🔬

Daniele dos Santos Lages possesses a robust set of research skills that equip her to address complex public health issues with analytical precision and social sensitivity. Her expertise spans epidemiological data analysis, qualitative and quantitative research design, health indicators assessment, and policy evaluation. She is proficient in statistical software and epidemiological tools used for surveillance and data interpretation, allowing her to derive actionable insights from large health datasets. Daniele also demonstrates strong competencies in scientific writing, grant proposal development, and knowledge translation for both academic and public audiences. She actively applies mixed-method approaches to explore healthcare access, disease distribution, and the effectiveness of Brazil’s health policies. In addition to technical skills, she excels in collaborative research, working across disciplines and institutions to contribute to national and international public health projects. Her fluency in Portuguese, English, and Spanish facilitates international collaboration, making her a versatile and globally relevant public health researcher.

Conclusion💡

Daniele dos Santos Lages exhibits exceptional promise and achievement as a public health researcher, particularly in the domain of leprosy surveillance and primary healthcare systems. Her strong academic background, dedication to neglected diseases, and proactive engagement in capacity-building initiatives mark her as a passionate and purpose-driven professional. Her research is not only scientifically relevant but socially responsive, aligning closely with global health equity goals. Although she would benefit from more diversified research themes and wider international exposure, her foundation is solid and future potential is significant. With continued interdisciplinary collaboration and publication in global platforms, Daniele is well-positioned to make substantial contributions to global public health. Therefore, she is a strong and deserving candidate for the Best Researcher Award, especially within categories that recognize early-career excellence, commitment to social determinants of health, and contributions to underrepresented health issues in vulnerable populations. Her work exemplifies the blend of academic rigor and societal relevance that such awards aim to honor.

Publications Top Noted✍️

  • Title: A baixa escolaridade está associada ao aumento de incapacidades físicas no diagnóstico de hanseníase no Vale do Jequitinhonha
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, FCF Lana
    Year: 2018
    Citations: 51

  • Title: Spatial analysis of the epidemiological risk of leprosy in the municipalities of Minas Gerais
    Authors: IC Bueno, DS Lages, FCF Lana
    Year: 2023
    Citations: 12

  • Title: Profile of the leprosy endemic in the district of Murrupula, Nampula, Mozambique: A population-based study
    Authors: GC Ribeiro, DS Lages, ATC Lages, VB Souza, A Marega, FCF Lana, …
    Year: 2023
    Citations: 4

  • Title: Consistência do registro dos casos de hanseníase no Sistema de Informação de Agravos de Notificação em Minas Gerais-período: 2017 a 2021
    Authors: GCS Reis, DS Lages, FCF Lana
    Year: 2024
    Citations: 2

  • Title: Avaliação do grau de incapacidade física por hanseníase em Minas Gerais
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, SL Vidal, …
    Year: 2022
    Citations: 2

  • Title: Spatial, Social and Serological Factors in the Prevalence and Risk of Leprosy in Areas of High Endemicity: An Integrative Review
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed (assumed 0 or pending)

  • Title: Análise da ocorrência de sífilis em gestantes em um município da Região Metropolitana de Belo Horizonte entre 2011 e 2021
    Authors: SL Dias, D dos Santos Lages, ICL Maciel, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: Correlation and Trends in Primary Health Care and Family Health Strategy Coverage of Leprosy Detection in Minas Gerais
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: An interrupted time series study of the leprosy case detection in Brazil after the COVID-19 pandemic
    Authors: GJB Sousa, DS Lages, PPL Barbosa, MCN Rocha, SA de Sena Neto, …
    Year: 2025
    Citations: Not listed

Hua Jin | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Ms. Hua Jin | Immunology and Microbiology | Best Researcher Award

Research Assistant at Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, China

Ms. Hua Jin is a highly accomplished researcher in hepatology and immunology. She holds an M.B. in clinical medicine and advanced degrees (M.S. and M.D.) in hepatology from Capital Medical University and Beijing Friendship Hospital, China. Currently, she works as a researcher at the Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital. Her research focuses on liver injury and immune responses, particularly the role of OX40 in hepatic ischemia-reperfusion injury and drug-induced liver damage. She has co-authored numerous high-impact publications in journals like JCI Insight, British Journal of Pharmacology, and Cell Reports. Her groundbreaking work has earned her recognition, including the prestigious American Transplant Congress Young Investigator Award in 2021. In addition to her research, she has presented her findings at major international conferences, including the Asian Pacific Association for the Study of the Liver and the American Transplant Congress.

Professional Profile

Education

Ms. Hua Jin has a strong academic background in clinical medicine and hepatology. She completed her undergraduate studies in Clinical Medicine at Chongqing Medical University in China, earning her M.B. degree from 2009 to 2014. Following this, she pursued advanced training in hepatology, earning her M.S. degree from the Experimental and Translational Research Center at Beijing Friendship Hospital, Capital Medical University, from 2015 to 2018. Building on this foundation, she furthered her expertise by obtaining an M.D. in hepatology, also from the Experimental and Translational Research Center, between 2018 and 2021. This rigorous education provided Ms. Jin with a deep understanding of both clinical and research aspects of hepatology, setting the stage for her current work in immunology and liver disease. Her academic achievements reflect a commitment to advancing knowledge in medical research, particularly in the areas of liver injury and immune system regulation.

Professional Experience

Ms. Hua Jin has extensive professional experience in the field of medical research, particularly in hepatology and immunology. After completing her advanced degrees, she began her research career as a Research Assistant at the Immunology Research Center for Oral and Systemic Health at Beijing Friendship Hospital, Capital Medical University, from 2021 to 2024. During this time, she worked on critical research related to immune responses in liver injury, with a focus on the role of OX40 in liver diseases. In 2024, she transitioned to her current role at the Medical Research Center, Beijing Institute of Respiratory Medicine, and Beijing Chao-Yang Hospital, where she continues her work in hepatology and immunology. Throughout her career, Ms. Jin has contributed to numerous high-impact research projects, authored multiple publications in prestigious journals, and presented her work at leading international conferences, establishing herself as a promising young investigator in the field of liver disease and immune system regulation.

Research interest

Ms. Hua Jin’s research interests primarily focus on hepatology, immunology, and liver diseases. Her work investigates the immune mechanisms underlying liver injury, particularly the role of immune checkpoints like OX40 in hepatic ischemia-reperfusion injury, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). She is particularly interested in how immune responses, both innate and adaptive, contribute to liver diseases, aiming to identify potential therapeutic targets for improving liver function and preventing damage. Her research also delves into the cellular and molecular dynamics of immune cells such as neutrophils and T cells in liver injury. Through the application of advanced techniques like single-cell transcriptomics, she explores the heterogeneity of immune cell populations and their roles in inflammation and liver repair. Ms. Jin’s work seeks to bridge the gap between basic immunology and clinical hepatology, with the goal of developing novel, immune-based therapeutic strategies for liver diseases.

Award and Honor

Ms. Hua Jin has received notable recognition for her research contributions, highlighting her prominence in the fields of hepatology and immunology. In 2021, she was honored with the prestigious American Transplant Congress Young Investigator Award, which acknowledges exceptional young researchers making significant strides in transplant medicine and immunology. This award reflects the high regard her work has garnered within the scientific community. Additionally, Ms. Jin has published multiple influential papers in top-tier journals, such as JCI Insight, Cell Reports, and British Journal of Pharmacology, further cementing her status as a rising star in medical research. Her innovative studies on immune responses in liver injury and the role of immune checkpoints like OX40 have gained widespread recognition. Furthermore, she has presented her research at prominent international conferences, including the Asian Pacific Association for the Study of the Liver and American Transplant Congress, showcasing her contributions to the global medical research community.

Conclusion

Hua Jin demonstrates the core qualities of an outstanding researcher: academic excellence, groundbreaking contributions, and recognition within his field. His work on immune responses in liver injury is cutting-edge and contributes valuable insights to the medical community. With continued growth in his research portfolio and a potential increase in his mentorship and international networking, he could further enhance his impact. Based on these strengths, Hua Jin is highly deserving of consideration for the Best Researcher Award.

Publications Top Noted

  • “Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD”
    • Authors: Sun, G., Wang, Y., Yang, L., Zhang, Z., Zhang, D.
    • Year: 2023
    • Citations: 5
  • Erratum to “Isolation and purification of immune cells from the liver”
    • Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
    • Year: 2023
    • Citations: 0
  • “OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis”
    • Authors: Xu, L., Tian, D., Zhou, M., Zhang, D., Wu, J.
    • Year: 2022
    • Citations: 2
  • “Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis”
    • Authors: Chen, S., Lv, T., Sun, G., Zhang, D., Jia, J.
    • Year: 2022
    • Citations: 6
  • “The Critical and Diverse Roles of CD4–CD8– Double Negative T Cells in Nonalcoholic Fatty Liver Disease”
    • Authors: Li, C., Du, X., Shen, Z., Zhang, D., Sun, G.
    • Year: 2022
    • Citations: 11
  • “CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis”
    • Authors: Sun, G., Zhao, X., Li, M., Zhang, Z., Zhang, D.
    • Year: 2021
    • Citations: 22
  • “Transcriptome landscape of double negative T cells by single-cell RNA sequencing”
    • Authors: Yang, L., Zhu, Y., Tian, D., Zhao, Y., Zhang, D.
    • Year: 2021
    • Citations: 26
  • “Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress”
    • Authors: Li, S., Jin, H., Sun, G., Zhang, D., Wang, S.
    • Year: 2021
    • Citations: 14
  • “Isolation and purification of immune cells from the liver”
    • Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
    • Year: 2020
    • Citations: 34
  • “Critical role of OX40 in drug-induced acute liver injury”
    • Authors: Zhang, C., Jin, H., Wang, Y., Sun, G., Zhang, D.
    • Year: 2020
    • Citations: 4

 

Ani Ioana Cotar | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ani Ioana Cotar | Immunology | Best Researcher Award

PhD, senior researcher at Cantacuzino Research Institute, Romania.

Dr. Ani Ioana Cotar is a distinguished research scientist and head of the National Center for Expertise and Intervention in Public Health for Biological, Chemical, Radiological, and Nuclear Agents at the “Cantacuzino” National Medico-Military Institute in Bucharest, Romania. Her career spans over 20 years, specializing in virology and vector-borne infections, including high-impact diseases such as West Nile, Zika, and Chikungunya viruses. Her expertise in molecular diagnostics and pathogen characterization has positioned her at the forefront of infectious disease research, with extensive experience in immunology and molecular biology techniques. Dr. Cotar’s significant role in global health initiatives is underscored by her work with the EVDLabNet and WHO in external quality assurance (EQA) schemes. Her commitment to advancing public health and her innovative research approaches make her a prominent figure in the field, with her contributions directly impacting diagnostic accuracy and understanding of viral pathogen epidemiology.

Professional Profile

Education

Dr. Cotar’s educational background includes a Ph.D. in Biology from the Faculty of Biology, University of Bucharest, completed in 2009. She holds an MSc in Genetics from the same institution and a BSc in Biology. Additionally, she completed two postdoctoral fellowships; one at the University of Bucharest, where she deepened her understanding of molecular biology, and the other under the European Program for Public Health Microbiology (EUPHEM) in Stockholm. This extensive education laid the groundwork for her career in vector-borne infections and public health. Her advanced studies, particularly in molecular epidemiology, prepared her for her pioneering role in pathogen identification and control. Dr. Cotar’s academic accomplishments highlight her commitment to integrating science with public health practices to improve diagnostic protocols and preventive strategies against infectious diseases.

Professional Experience

Dr. Cotar began her career at the “Cantacuzino” Institute in 2001 as a biologist and progressed to roles of increasing responsibility, becoming a Research Scientist I by 2022 and Head of the National Center in 2023. Her experience includes leading projects on the molecular diagnostics of high-risk vector-borne pathogens and implementing quality assurance testing for the WHO. Her work includes crucial contributions to SARS-CoV-2 diagnostics during the pandemic and coordinating whole-genome sequencing for bacterial pathogens. She has developed protocols for DNA/RNA extraction, PCR, and real-time PCR, bringing rigorous scientific standards to her laboratory’s practices. Her leadership and technical expertise have contributed to significant advancements in Romania’s capacity to detect, monitor, and respond to infectious disease threats, particularly in vector-borne pathogens affecting both national and global health landscapes.

Research Interest

Dr. Cotar’s research interests lie in the molecular epidemiology and diagnostics of viral and bacterial vector-borne pathogens. Her work focuses on identifying and characterizing infectious agents such as West Nile, Zika, and Chikungunya viruses, as well as bacterial pathogens like Rickettsia and Borrelia. She is committed to improving diagnostic capabilities through molecular biology techniques, including PCR, DNA sequencing, and bioinformatics. Dr. Cotar’s research extends to quality assurance, participating in global quality initiatives that enhance laboratory accuracy for pathogen detection. Her expertise in molecular typing and genome sequencing reflects her focus on understanding pathogen transmission, evolution, and resistance, critical for developing effective public health interventions.

Award and Honor

Dr. Cotar has been recognized for her contributions to public health and infectious disease research. Her work on the frontlines of SARS-CoV-2 diagnostics and her efforts to establish protocols for emerging viral and bacterial pathogens have earned her respect within the scientific community. She has received accolades for her role in quality assurance initiatives with the WHO and her contributions to the EVDLabNet. These recognitions underscore her commitment to improving diagnostic accuracy and public health response capabilities, and her dedication has positioned her as an authority in virology and infectious disease research in Romania and beyond.

Conclusion

Dr. Cotar’s deep specialization in vector-borne infectious diseases, coupled with her proven track record in molecular diagnostics and quality assurance, establishes her as a leading candidate for the Best Researcher Award. Her consistent contributions are essential to advancing both national and global health research on infectious diseases.

Publications top noted

Title: Increasing the Awareness of Under-Diagnosed Tropical Cases of Dengue in Romania
Authors: Cismaru, I.M., Radu, M.A., Cotar, A.I., Ghemulet, I., Gheorghita, V.
Year: 2023
Citation: Tropical Medicine and Infectious Disease, 2023, 8(10), 469.

Title: First Detection and Molecular Characterization of Usutu Virus in Culex pipiens Mosquitoes Collected in Romania
Authors: Prioteasa, F.L., Dinu, S., Tiron, G.V., Ceianu, C.S., Cotar, A.I.
Year: 2023
Citation: Microorganisms, 2023, 11(3), 684.

Title: Distribution of Insecticide Resistance Genetic Markers in the West Nile Virus Vector Culex pipiens from South-Eastern Romania
Authors: Stancu, I.G., Prioteasa, F.L., Tiron, G.V., Ceianu, C.S., Csutak, O.
Year: 2022
Citation: Insects, 2022, 13(11), 1062.

Title: Original Contributions to the Chemical Composition, Microbicidal, Virulence-Arresting, and Antibiotic-Enhancing Activity of Essential Oils from Four Coniferous Species
Authors: Visan, D.-C., Oprea, E., Radulescu, V., Chifiriuc, M.C., Marinas, I.C.
Year: 2021
Citation: Pharmaceuticals, 2021, 14(11), 1159.

Title: Characterization and Host-Feeding Patterns of Culex pipiens s.l. Taxa in a West Nile Virus-Endemic Area in Southeastern Romania
Authors: Tiron, G.V., Stancu, I.G., Dinu, S., Ceianu, C.S., Cotar, A.I.
Year: 2021
Citation: Vector-Borne and Zoonotic Diseases, 2021, 21(9), pp. 713–719.

Title: Emergence of Toscana Virus, Romania, 2017-2018
Authors: Popescu, C.P., Cotar, A.I., Dinu, S., Ceianu, C.S., Florescu, S.A.
Year: 2021
Citation: Emerging Infectious Diseases, 2021, 27(5), pp. 1482–1485.

Title: Increased Risk of Chikungunya Infection in Travelers to Thailand During Ongoing Outbreak in Tourist Areas: Cases Imported to Europe and the Middle East, Early 2019
Authors: Javelle, E., Florescu, S.-A., Asgeirsson, H., Hamer, D.H., Gautret, P.
Year: 2019
Citation: Eurosurveillance, 2019, 24(10), 1900146.

Title: West Nile Virus Lineage 2 in Romania, 2015-2016: Co-Circulation and Strain Replacement
Authors: Cotar, A.I., Fǎlcuţǎ, E., Dinu, S., Ceianu, C.S., Prioteasa, F.L.
Year: 2018
Citation: Parasites and Vectors, 2018, 11(1), 562.

Title: Re-Emergence of Severe West Nile Virus Neuroinvasive Disease in Humans in Romania, 2012 to 2017 – Implications for Travel Medicine
Authors: Popescu, C.P., Florescu, S.A., Cotar, A.I., Ceausu, E., Ruta, S.M.
Year: 2018
Citation: Travel Medicine and Infectious Disease, 2018, 22, pp. 30–35.

Title: Lack of Zika Virus Antibody Response in Confirmed Patients in Non-Endemic Countries
Authors: Lustig, Y., Cotar, A.I., Ceianu, C.S., Aarons, E., Reusken, C.
Year: 2018
Citation: Journal of Clinical Virology, 2018, 99-100, pp. 31–34.

Jean-nicolas boursiquot | Immunology | Best Researcher Award

Published on by Global Scholar Awards

🌟Dr. Jean-nicolas boursiquot, Immunology, Best Researcher Award 🏆

  •  Doctorate at CHU de Quebec, Canada
 

Jean-Nicolas Boursiquot is a highly qualified medical professional specializing in allergy and clinical immunology. With a comprehensive educational background and extensive research experience, Boursiquot has made significant contributions to the field through publications, presentations, and teaching activities. His dedication to advancing medical knowledge and patient care is evident in his multifaceted professional journey, marked by numerous affiliations, academic commitments, and media engagements. Boursiquot’s expertise encompasses a wide range of topics within allergy and immunology, making him a respected figure in both academic and clinical settings.

Author Metrics:

Scopus Profile

Boursiquot’s author metrics reflect a prolific and impactful academic career, with a substantial number of publications in peer-reviewed journals, presentations at scientific conferences, and media engagements.

  • Citations: 385 citations by 385 documents
  • Documents: 9
  • h-index: 5

Education:

  • Ph.D. in Medicine (M.D.), Laval University, Quebec, Canada, 1999-2004
  • Intensive ESL (English as Second Language) Training, University of Manitoba, Winnipeg, Canada, 1999
  • International Baccalaureate (Pure Sciences), Small Seminary of Quebec, Quebec, Canada, 1997-1999

Research Focus:

Boursiquot’s research focuses primarily on allergy and clinical immunology, with particular interests in immunodeficiencies, allergic rhinitis, asthma, drug allergies, and angioedema. He has conducted studies on various aspects of these conditions, contributing to advancements in diagnosis, treatment, and understanding of underlying mechanisms.

Professional Journey:

Boursiquot’s professional journey spans diverse roles in academia, clinical practice, research, and education:

  • Clinical Allergist and Immunologist at CSSS DES ILES and CSSS DE LAC-SAINT-JEAN-EST
  • Clinical Professor and Educational Ambassador at Laval University
  • Member of various professional committees and boards, including the Canadian Society of Allergy and Clinical Immunology (CSACI) and the Association of Allergists and Immunologists of Quebec (AAIQ)
  • Active involvement in medical education and training, including teaching medical students, residents, and clinicians

Honors & Awards:

  • Recipient of the CMDP of CHUQ and CHUQ-CMDP Foundation Award in 2010
  • Awarded the Humanism Prize in 1997 by the Small Seminary of Quebec

Research Timeline:

1999-2004: Pursued Ph.D. in Medicine at Laval University, Quebec, Canada

2007-2009: Completed Residency in Allergy and Clinical Immunology at McGill University, Montreal, Canada

2010: Conducted Research Fellowship at Pr Éric Oksenhendler Service, St-Louis Hospital, Paris, France

2013-present: Actively engaged in clinical practice, research, teaching, and professional development, making significant contributions to the field of allergy and clinical immunology.

Publications Noted & Contributions:

Boursiquot has made significant contributions to the medical literature through published articles, scientific posters, and presentations at conferences. His research has been focused on topics such as immunodeficiencies, allergic reactions, and treatment strategies. He has also engaged with the media to raise awareness and educate the public about allergies and related conditions.

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

  • Authors: Brillant-Marquis, F., Proulx, É., Ratnarajah, K., De Serres, G., Drolet, J.-P., Boursiquot, J.-N.
  • Journal: Journal of Allergy and Clinical Immunology: In Practice, 2024, 12(2), pp. 451–457.e2
  • Abstract: [Not available]
  • Citations: 1
  • Note: Open access

A Patient Charter for Chronic Urticaria

  • Authors: Maurer, M., Albuquerque, M., Boursiquot, J.-N., Nigen, S., Winders, T.
  • Journal: Advances in Therapy, 2024, 41(1), pp. 14–33
  • Abstract: [Not available]
  • Citations: 0
  • Review: Open access

Bradykinin-induced angioedema in the emergency department

  • Authors: Hébert, J., Boursiquot, J.-N., Chapdelaine, H., Lepeshkina, O., Vincent, M.
  • Journal: International Journal of Emergency Medicine, 2022, 15(1), 15
  • Abstract: [Not available]
  • Citations: 2
  • Erratum: Open access

Erratum: The International/Canadian Hereditary Angioedema Guideline

  • Authors: Betschel, S., Badiou, J., Binkley, K., Stark, D., Tsai, E.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 16
  • Abstract: [Not available]
  • Citations: 1
  • Erratum: Open access

Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: A parallel physician-patient survey

  • Authors: Ellis, A.K., Boursiquot, J., Carr, S., Graham, F., Masse, M.-S.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 15
  • Abstract: [Not available]
  • Citations: 8